Dynamo Medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dynamo Medical
Largest movements
- Stocks and contracts -€11,462
down €11,462 (-74.7%), from €15,345 to €3,883
- Cash +€5,559
up €5,559 (+127%), from €4,365 to €9,924
mainly Tax, wage and social debts (+€16,598) and Other debts (+€14,484)
- Deferred charges and accrued income +€3,536
new in 2025: €3,536
- Profit (loss) carried forward -€18,278
down €18,278 (-23.4%), from -€77,954 to -€96,231
- Tax, wage and social debts +€16,598
up €16,598 (+4,748%), from €350 to €16,948
of which Taxes: +€16,598
- Trade debts -€15,079
down €15,079 (-52.3%), from €28,834 to €13,755
- Other debts +€14,484
up €14,484 (+19.9%), from €72,638 to €87,122
- Staff costs -€39,007
down €39,007 (-99.9%), from €39,027 to €20
- Gross operating margin +€7,809
up €7,809, from -€2,446 to €5,363
- Taxes +€4,935
up €4,935 (+41.7%), from €11,838 to €16,773
- Other operating charges +€2,468
up €2,468 (+69.1%), from €3,569 to €6,037
- Financial charges +€70
up €70 (+9.5%), from €740 to €810
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €27,368 | €25,094 | -€2,275 | -8.3% |
| Current assets | 29/58 | €27,368 | €25,094 | -€2,275 | -8.3% |
| Stocks and contracts in progress | 3 | €15,345 | €3,883 | -€11,462 | -74.7% |
| Stocks | 30/36 | €15,345 | €3,883 | -€11,462 | -74.7% |
| Amounts receivable within one year | 40/41 | €7,658 | €7,751 | +€93 | +1.2% |
| Trade receivables | 40 | €1,686 | €1,686 | = | 0.0% |
| Other amounts receivable | 41 | €5,972 | €6,064 | +€93 | +1.6% |
| Cash at bank and in hand | 54/58 | €4,365 | €9,924 | +€5,559 | +127% |
| Deferred charges and accrued income | 490/1 | - | €3,536 | +€3,536 | |
| Total equity and liabilities | 10/49 | €27,368 | €25,094 | -€2,275 | -8.3% |
| Equity | 10/15 | -€74,454 | -€92,731 | -€18,278 | -24.5% |
| Contributions | 10/11 | €3,500 | €3,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€77,954 | -€96,231 | -€18,278 | -23.4% |
| Amounts payable | 17/49 | €101,822 | €117,825 | +€16,003 | +15.7% |
| Amounts payable within one year | 42/48 | €101,822 | €117,825 | +€16,003 | +15.7% |
| Trade debts | 44 | €28,834 | €13,755 | -€15,079 | -52.3% |
| Suppliers | 440/4 | €28,834 | €13,755 | -€15,079 | -52.3% |
| Taxes, remuneration and social security | 45 | €350 | €16,948 | +€16,598 | +4,748% |
| Taxes | 450/3 | €175 | €16,773 | +€16,598 | +9,485% |
| Remuneration and social security | 454/9 | €175 | €175 | = | 0.0% |
| Other amounts payable | 47/48 | €72,638 | €87,122 | +€14,484 | +19.9% |
| Remuneration, social security and pensions | 62 | €39,027 | €20 | -€39,007 | -99.9% |
| Other operating charges | 640/8 | €3,569 | €6,037 | +€2,468 | +69.1% |
| Gross operating margin | 9900 | -€2,446 | €5,363 | +€7,809 | |
| Operating profit (loss) | 9901 | -€45,043 | -€695 | +€44,348 | +98.5% |
| Financial charges | 65/66B | €740 | €810 | +€70 | +9.5% |
| Recurring financial charges | 65 | €740 | €810 | +€70 | +9.5% |
| Profit (loss) for the period before taxes | 9903 | -€45,782 | -€1,505 | +€44,278 | +96.7% |
| Income taxes | 67/77 | €11,838 | €16,773 | +€4,935 | +41.7% |
| Profit (loss) for the period | 9904 | -€57,620 | -€18,278 | +€39,343 | +68.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€57,620 | -€18,278 | +€39,343 | +68.3% |
Source: filed annual accounts (NBB), financial years ended 30 April 2024 and 30 April 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.